6,587 research outputs found

    The Impact of Tobacco Control Program Expenditures on Aggregate Cigarette Sales: 1981-1998

    Get PDF
    Since the 1998 Master Settlement Agreement between states and the tobacco industry, states have unprecedented resources for programs to reduce tobacco use. Decisions concerning the use of these funds will, in part, be based on the experiences of states with existing programs. We review the experiences of several states that have adopted comprehensive tobacco control programs. We also report estimates from econometric analyses of the impact of tobacco control expenditures on aggregate tobacco use in all states and in selected states with comprehensive programs for the period from 1981 through 1998. Our analyses clearly show that increases in funding for state tobacco control programs reduce tobacco use.

    Trapped-ion quantum error-correcting protocols using only global operations

    Full text link
    Quantum error-correcting codes are many-body entangled states that are prepared and measured using complex sequences of entangling operations. Each element of such an entangling sequence introduces noise to delicate quantum information during the encoding or reading out of the code. It is important therefore to find efficient entangling protocols to avoid the loss of information. Here we propose an experiment that uses only global entangling operations to encode an arbitrary logical qubit to either the five-qubit repetition code or the five-qubit code, with a six-ion Coulomb crystal architecture in a Penning trap. We show that the use of global operations enables us to prepare and read out these codes using only six and ten global entangling pulses, respectively. The proposed experiment also allows the acquisition of syndrome information during readout. We provide a noise analysis for the presented protocols, estimating that we can achieve a six-fold improvement in coherence time with noise as high as ∼1%\sim 1\% on each entangling operation.Comment: 7 pages, 4 figures, published version, comments are welcom

    Analysis of the Health Product Profile Directory - a new tool to inform priority-setting in global public health

    Get PDF
    Background: The Health Product Profile Directory (HPPD) is an online database describing 8–10 key characteristics (such as target population, measures of efficacy and dosage) of product profiles for medicines, vaccines, diagnostics and other products that are intended to be accessed by populations in low- and middle-income countries. The HPPD was developed by TDR on behalf of WHO and launched on 15 May 2019. Methods: The contents of the HPPD were downloaded into an Excel™ spreadsheet via the open access interface and analysed to identify the number of health product profiles by type, disease, year of publication, status, author organization and safety information. Results: The HPPD contains summaries of 215 health product profiles published between 2008 and May 2019, 117 (54%) of which provide a hyperlink to the detailed publication from which the summary was extracted, and the remaining 98 provide an email contact for further information. A total of 55 target disease or health conditions are covered, with 210 profiles describing a product with an infectious disease as the target. Only 5 product profiles in the HPPD describe a product for a non-communicable disease. Four diseases account for 40% of product profiles in the HPPD; these are tuberculosis (33 profiles, 15%), malaria (31 profiles, 14%), HIV (13 profiles, 6%) and Chagas (10 profiles, 5%). Conclusion: The HPPD provides a new tool to inform priority-setting in global health — it includes all product profiles authored by WHO (n = 51). There is a need to standardise nomenclature to more clearly distinguish between strategic publications (describing research and development (R&D) priorities or preferred characteristics) compared to target product profiles to guide a specific candidate product undergoing R&D. It is recommended that all profiles published in the HPPD define more clearly what affordability means in the context where the product is intended to be used and all profiles should include a statement of safety. Combining the analysis from HPPD to a mapping of funds available for R&D and those products in the R&D pipeline would create a better overview of global health priorities and how they are supported. Such analysis and increased transparency should take us a step closer to measuring and improving coordination of efforts in global health R&D

    Developmental dyscalculia and low numeracy in Chinese children

    Get PDF
    Children struggle with mathematics for different reasons. Developmental dyscalculia and low numeracy - two kinds of mathematical difficulties - may have their roots, respectively, in poor understanding of exact non-symbolic numerosities and of symbolic numerals. This study was the first to explore whether Chinese children, despite cultural and linguistic factors supporting their mathematical learning, also showed such mathematical difficulties and whether such difficulties have measurable impact on children's early school mathematical performance. First-graders, classified as dyscalculia, low numeracy, or normal achievement, were compared for their performance in various school mathematical tasks requiring a grasp of non-symbolic numerosities (i.e., non-symbolic tasks) or an understanding of symbolic numerals (i.e., symbolic tasks). Children with dyscalculia showed poorer performance than their peers in non-symbolic tasks but not symbolic ones, whereas those with low numeracy showed poorer performance in symbolic tasks but not non-symbolic ones. As hypothesized, these findings suggested that dyscalculia and low numeracy were distinct deficits and caused by deficits in non-symbolic and symbolic processing, respectively. These findings went beyond prior research that only documented generally low mathematical achievements for these two groups of children. Moreover, these deficits appeared to be persistent and could not be remedied simply through day-to-day school mathematical learning. The present findings highlighted the importance of tailoring early learning support for children with these distinct deficits, and pointed to future directions for the screening of such mathematical difficulties among Chinese children. © 2013 Elsevier Ltd.postprin

    Bimodal release ondansetron for acute gastroenteritis among adolescents and adults: A randomized clinical trial

    Get PDF
    Importance: Vomiting resulting from acute gastroenteritis is commonly treated with intravenous antiemetics in acute care settings. If oral treatment were beneficial, patients might not need intravenous administered hydration or medication. Furthermore, a long-acting treatment could provide sustained relief from nausea and vomiting. Objective: To determine whether an experimental long-acting bimodal release ondansetron tablet decreases gastroenteritis-related vomiting and eliminates the need for intravenous therapy for 24 hours after administration. Design, Setting, and Participants: This placebo-controlled, double-blind, randomized clinical trial included patients from 19 emergency departments and 2 urgent care centers in the United States from December 8, 2014, to February 17, 2017. Patients 12 years and older with at least 2 vomiting episodes from presumed gastroenteritis in the previous 4 hours and symptoms with less than 36 hours\u27 duration were randomized using a 3:2 active to placebo ratio. Analyses were performed on an intent-to-treat basis and conducted from June 1, 2017, to November 1, 2017. Intervention: Bimodal release ondansetron tablet containing 6 mg of immediate release ondansetron and 18 mg of a 24-hour release matrix for a total of 24 mg of ondansetron. Main Outcomes and Measures: Treatment success was defined as no further vomiting, no need for rescue medication, and no intravenous hydration for 24 hours after bimodal release ondansetron administration. Results: Analysis included 321 patients (mean [SD] age, 29.0 [11.1] years; 195 [60.7%] women), with 192 patients in the bimodal release ondansetron group and 129 patients in the placebo group. Treatment successes were observed in 126 patients in the bimodal release ondansetron group (65.6%) compared with 70 patients in the placebo group (54.3%), with an 11.4% (95% CI, 0.3%-22.4%) absolute probability difference. The proportion of treatment success was 21% higher among patients who received bimodal release ondansetron compared with those who received a placebo (relative risk, 1.21; 95% CI, 1.00-1.46; P = .04). In an analysis including only patients with a discharge diagnosis of acute gastroenteritis and no major protocol violations, there were 123 treatment successes (69.5%) in the bimodal release ondansetron group compared with 67 treatment successes (54.9%) in the placebo group (relative risk, 1.27; 95% CI, 1.05-1.53; P = .01). Adverse effects were infrequent and similar to the known safety profile of ondansetron. Conclusions and Relevance: This randomized clinical trial found that a long-acting bimodal release oral ondansetron tablet was an effective antiemetic among adolescents and adults with moderate to severe vomiting from acute gastroenteritis. The drug benefits extended to 24 hours after administration. Bimodal release ondansetron may decrease the need for intravenous access and emergency department care to manage acute gastroenteritis. Trial Registration: ClinicalTrials.gov identifier: NCT02246439

    Spectroscopy of the odd-odd fp-shell nucleus 52Sc from secondary fragmentation

    Get PDF
    The odd-odd fp-shell nucleus 52Sc was investigated using in-beam gamma-ray spectroscopy following secondary fragmentation of a 55V and 57Cr cocktail beam. Aside from the known gamma-ray transition at 674(5)keV, a new decay at E_gamma=212(3) keV was observed. It is attributed to the depopulation of a low-lying excited level. This new state is discussed in the framework of shell-model calculations with the GXPF1, GXPF1A, and KB3G effective interactions. These calculations are found to be fairly robust for the low-lying level scheme of 52Sc irrespective of the choice of the effective interaction. In addition, the frequency of spin values predicted by the shell model is successfully modeled by a spin distribution formulated in a statistical approach with an empirical, energy-independent spin-cutoff parameter.Comment: accepted for publication in PR
    • …
    corecore